nodes	percent_of_prediction	percent_of_DWPC	metapath
Flumethasone Pivalate—NR3C1—prostate cancer	0.406	1	CbGaD
Flumethasone Pivalate—NR3C1—Prednisone—prostate cancer	0.0547	1	CbGbCtD
Flumethasone Pivalate—Fluocortolone—Prednisone—prostate cancer	0.0332	0.0705	CrCrCtD
Flumethasone Pivalate—Alclometasone—Prednisone—prostate cancer	0.0323	0.0685	CrCrCtD
Flumethasone Pivalate—Amcinonide—Prednisone—prostate cancer	0.0314	0.0667	CrCrCtD
Flumethasone Pivalate—Diflorasone—Prednisone—prostate cancer	0.0306	0.0649	CrCrCtD
Flumethasone Pivalate—Flunisolide—Prednisone—prostate cancer	0.0306	0.0649	CrCrCtD
Flumethasone Pivalate—Clobetasol propionate—Prednisone—prostate cancer	0.0306	0.0649	CrCrCtD
Flumethasone Pivalate—Paramethasone—Prednisone—prostate cancer	0.0298	0.0633	CrCrCtD
Flumethasone Pivalate—Desoximetasone—Prednisone—prostate cancer	0.0291	0.0618	CrCrCtD
Flumethasone Pivalate—Fluprednidene Acetate—Prednisone—prostate cancer	0.0284	0.0603	CrCrCtD
Flumethasone Pivalate—Fluorometholone—Prednisone—prostate cancer	0.0284	0.0603	CrCrCtD
Flumethasone Pivalate—Mometasone—Prednisone—prostate cancer	0.0284	0.0603	CrCrCtD
Flumethasone Pivalate—Triamcinolone—Prednisone—prostate cancer	0.0284	0.0603	CrCrCtD
Flumethasone Pivalate—Rimexolone—Prednisone—prostate cancer	0.0278	0.0589	CrCrCtD
Flumethasone Pivalate—Betamethasone—Prednisone—prostate cancer	0.0278	0.0589	CrCrCtD
Flumethasone Pivalate—Dexamethasone—Prednisone—prostate cancer	0.0278	0.0589	CrCrCtD
Flumethasone Pivalate—Methylprednisolone—Prednisone—prostate cancer	0.0266	0.0564	CrCrCtD
Flumethasone Pivalate—NR3C1—urine—prostate cancer	0.00183	0.26	CbGeAlD
Flumethasone Pivalate—Sensitisation—Epirubicin—prostate cancer	0.00116	0.0424	CcSEcCtD
Flumethasone Pivalate—Sensitisation—Doxorubicin—prostate cancer	0.00108	0.0392	CcSEcCtD
Flumethasone Pivalate—SERPINA6—renal system—prostate cancer	0.00103	0.145	CbGeAlD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—TMPRSS2—prostate cancer	0.000989	0.0364	CbGpPWpGaD
Flumethasone Pivalate—Burning sensation—Docetaxel—prostate cancer	0.000887	0.0323	CcSEcCtD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—HOXB13—prostate cancer	0.000841	0.031	CbGpPWpGaD
Flumethasone Pivalate—SERPINA6—bone marrow—prostate cancer	0.000775	0.11	CbGeAlD
Flumethasone Pivalate—NR3C1—FOXA2 and FOXA3 transcription factor networks—FOXA3—prostate cancer	0.00074	0.0273	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Estramustine—prostate cancer	0.000684	0.0249	CcSEcCtD
Flumethasone Pivalate—Amcinonide—ANXA1—prostate cancer	0.00066	0.108	CrCbGaD
Flumethasone Pivalate—NR3C1—prostate gland—prostate cancer	0.000659	0.0932	CbGeAlD
Flumethasone Pivalate—Pruritus—Estrone—prostate cancer	0.000653	0.0238	CcSEcCtD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—KLK3—prostate cancer	0.000637	0.0235	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—KLF15—prostate cancer	0.000637	0.0235	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—SPOCK1—prostate cancer	0.000637	0.0235	CbGpPWpGaD
Flumethasone Pivalate—Rash—Estramustine—prostate cancer	0.000609	0.0222	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Estramustine—prostate cancer	0.000609	0.0222	CcSEcCtD
Flumethasone Pivalate—Pruritus—Nilutamide—prostate cancer	0.000607	0.0221	CcSEcCtD
Flumethasone Pivalate—Pruritus—Flutamide—prostate cancer	0.000604	0.022	CcSEcCtD
Flumethasone Pivalate—NR3C1—FOXA2 and FOXA3 transcription factor networks—FOXA1—prostate cancer	0.000603	0.0222	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—KLK2—prostate cancer	0.000599	0.0221	CbGpPWpGaD
Flumethasone Pivalate—Burning sensation—Epirubicin—prostate cancer	0.000598	0.0218	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.000594	0.0216	CcSEcCtD
Flumethasone Pivalate—Rash—Abiraterone—prostate cancer	0.000592	0.0215	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Abiraterone—prostate cancer	0.000591	0.0215	CcSEcCtD
Flumethasone Pivalate—Rash—Estrone—prostate cancer	0.000582	0.0212	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Estrone—prostate cancer	0.000582	0.0212	CcSEcCtD
Flumethasone Pivalate—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.00057	0.0208	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Degarelix—prostate cancer	0.000565	0.0205	CcSEcCtD
Flumethasone Pivalate—NR3C1—seminal vesicle—prostate cancer	0.000557	0.0789	CbGeAlD
Flumethasone Pivalate—Burning sensation—Doxorubicin—prostate cancer	0.000554	0.0202	CcSEcCtD
Flumethasone Pivalate—Pruritus—Degarelix—prostate cancer	0.000542	0.0197	CcSEcCtD
Flumethasone Pivalate—Rash—Nilutamide—prostate cancer	0.000541	0.0197	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Nilutamide—prostate cancer	0.00054	0.0197	CcSEcCtD
Flumethasone Pivalate—Rash—Flutamide—prostate cancer	0.000538	0.0196	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Flutamide—prostate cancer	0.000538	0.0196	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Cabazitaxel—prostate cancer	0.000532	0.0194	CcSEcCtD
Flumethasone Pivalate—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000508	0.0185	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000508	0.0185	CcSEcCtD
Flumethasone Pivalate—NR3C1—epithelium—prostate cancer	0.000484	0.0685	CbGeAlD
Flumethasone Pivalate—Rash—Degarelix—prostate cancer	0.000483	0.0176	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Degarelix—prostate cancer	0.000483	0.0176	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Bicalutamide—prostate cancer	0.000456	0.0166	CcSEcCtD
Flumethasone Pivalate—NR3C1—renal system—prostate cancer	0.000449	0.0636	CbGeAlD
Flumethasone Pivalate—NR3C1—urethra—prostate cancer	0.000441	0.0624	CbGeAlD
Flumethasone Pivalate—Pruritus—Bicalutamide—prostate cancer	0.000438	0.0159	CcSEcCtD
Flumethasone Pivalate—NR3C1—Endoderm Differentiation—FOXA1—prostate cancer	0.000426	0.0157	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—EGR1—prostate cancer	0.000423	0.0156	CbGpPWpGaD
Flumethasone Pivalate—Rash—Bicalutamide—prostate cancer	0.00039	0.0142	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Bicalutamide—prostate cancer	0.00039	0.0142	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000386	0.014	CcSEcCtD
Flumethasone Pivalate—Pruritus—Ethinyl Estradiol—prostate cancer	0.00037	0.0135	CcSEcCtD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—NKX3-1—prostate cancer	0.000355	0.0131	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Transcription factor regulation in adipogenesis—RXRA—prostate cancer	0.000353	0.013	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—bone marrow—prostate cancer	0.000339	0.0481	CbGeAlD
Flumethasone Pivalate—NR3C1—Endoderm Differentiation—LAMC1—prostate cancer	0.000336	0.0124	CbGpPWpGaD
Flumethasone Pivalate—Rash—Ethinyl Estradiol—prostate cancer	0.00033	0.012	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00033	0.012	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Goserelin—prostate cancer	0.000317	0.0115	CcSEcCtD
Flumethasone Pivalate—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000314	0.0114	CcSEcCtD
Flumethasone Pivalate—NR3C1—Adipogenesis—LIFR—prostate cancer	0.000311	0.0115	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—KLF6—prostate cancer	0.000311	0.0115	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—MT2A—prostate cancer	0.000309	0.0114	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Goserelin—prostate cancer	0.000305	0.0111	CcSEcCtD
Flumethasone Pivalate—Pruritus—Conjugated Estrogens—prostate cancer	0.000302	0.011	CcSEcCtD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—PENK—prostate cancer	0.000293	0.0108	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—LAMC1—prostate cancer	0.000292	0.0108	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA2—prostate cancer	0.00029	0.0107	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—testis—prostate cancer	0.00029	0.0411	CbGeAlD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX1—prostate cancer	0.00028	0.0103	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Endoderm Differentiation—HNF1B—prostate cancer	0.000274	0.0101	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Endoderm Differentiation—BMP7—prostate cancer	0.000274	0.0101	CbGpPWpGaD
Flumethasone Pivalate—Rash—Goserelin—prostate cancer	0.000272	0.00988	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Goserelin—prostate cancer	0.000271	0.00988	CcSEcCtD
Flumethasone Pivalate—Rash—Conjugated Estrogens—prostate cancer	0.000269	0.00979	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Conjugated Estrogens—prostate cancer	0.000269	0.00978	CcSEcCtD
Flumethasone Pivalate—NR3C1—Adipogenesis—ID3—prostate cancer	0.000264	0.00974	CbGpPWpGaD
Flumethasone Pivalate—Dexamethasone—CYP3A43—prostate cancer	0.000262	0.043	CrCbGaD
Flumethasone Pivalate—NR3C1—Nuclear Receptors—ESR2—prostate cancer	0.00026	0.00957	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Transcription factor regulation in adipogenesis—LEP—prostate cancer	0.000256	0.00942	CbGpPWpGaD
Flumethasone Pivalate—Hypersensitivity—Estradiol—prostate cancer	0.000252	0.00916	CcSEcCtD
Flumethasone Pivalate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA1—prostate cancer	0.000245	0.00901	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Estradiol—prostate cancer	0.000242	0.00879	CcSEcCtD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—ASCL1—prostate cancer	0.000239	0.00882	CbGpPWpGaD
Flumethasone Pivalate—Hypersensitivity—Mitoxantrone—prostate cancer	0.000234	0.00853	CcSEcCtD
Flumethasone Pivalate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—RXRA—prostate cancer	0.000233	0.00857	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Nuclear Receptors—AR—prostate cancer	0.000229	0.00846	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—prostate cancer	0.000229	0.00846	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Transcription factor regulation in adipogenesis—IRS1—prostate cancer	0.000228	0.0084	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Nuclear Receptors—RXRA—prostate cancer	0.000228	0.00839	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—NPPA—prostate cancer	0.000222	0.00818	CbGpPWpGaD
Flumethasone Pivalate—Difluprednate—NR3C1—prostate cancer	0.000222	0.0363	CrCbGaD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—NCOA2—prostate cancer	0.000218	0.00802	CbGpPWpGaD
Flumethasone Pivalate—Rash—Estradiol—prostate cancer	0.000215	0.00784	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Estradiol—prostate cancer	0.000215	0.00783	CcSEcCtD
Flumethasone Pivalate—Clocortolone—NR3C1—prostate cancer	0.000215	0.0352	CrCbGaD
Flumethasone Pivalate—NR3C1—Circadian Clock—NCOA2—prostate cancer	0.000211	0.00779	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—lymph node—prostate cancer	0.00021	0.0298	CbGeAlD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—ATF3—prostate cancer	0.00021	0.00775	CbGpPWpGaD
Flumethasone Pivalate—Dexamethasone—ANXA1—prostate cancer	0.000207	0.034	CrCbGaD
Flumethasone Pivalate—NR3C1—Nuclear Receptors—VDR—prostate cancer	0.000206	0.0076	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Nuclear Receptor transcription pathway—ESR2—prostate cancer	0.000205	0.00757	CbGpPWpGaD
Flumethasone Pivalate—Diflorasone—NR3C1—prostate cancer	0.000204	0.0333	CrCbGaD
Flumethasone Pivalate—Rash—Mitoxantrone—prostate cancer	0.000201	0.0073	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Mitoxantrone—prostate cancer	0.0002	0.00729	CcSEcCtD
Flumethasone Pivalate—Desoximetasone—NR3C1—prostate cancer	0.000198	0.0325	CrCbGaD
Flumethasone Pivalate—Hypersensitivity—Etoposide—prostate cancer	0.000195	0.0071	CcSEcCtD
Flumethasone Pivalate—NR3C1—Endoderm Differentiation—PTHLH—prostate cancer	0.000193	0.00712	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Etoposide—prostate cancer	0.000187	0.00681	CcSEcCtD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—prostate cancer	0.000187	0.00689	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—EGR1—prostate cancer	0.000186	0.00686	CbGpPWpGaD
Flumethasone Pivalate—Beclomethasone—CYP3A5—prostate cancer	0.000186	0.0304	CrCbGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—MIF—prostate cancer	0.000185	0.00681	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—NCOA1—prostate cancer	0.000183	0.00676	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Nuclear Receptor transcription pathway—AR—prostate cancer	0.000181	0.00668	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Nuclear Receptor transcription pathway—RXRA—prostate cancer	0.00018	0.00663	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Circadian Clock—NCOA1—prostate cancer	0.000178	0.00656	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—prostate cancer	0.000178	0.00655	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Endoderm Differentiation—EZH2—prostate cancer	0.000176	0.00648	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—AR—prostate cancer	0.000176	0.00648	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—prostate cancer	0.000175	0.00647	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—RXRA—prostate cancer	0.000174	0.00643	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Nuclear Receptors—PPARA—prostate cancer	0.000174	0.00641	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Circadian Clock—RXRA—prostate cancer	0.000169	0.00624	CbGpPWpGaD
Flumethasone Pivalate—Halobetasol Propionate—NR3C1—prostate cancer	0.000168	0.0275	CrCbGaD
Flumethasone Pivalate—Rash—Etoposide—prostate cancer	0.000167	0.00607	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Etoposide—prostate cancer	0.000167	0.00607	CcSEcCtD
Flumethasone Pivalate—NR3C1—Nuclear Receptor transcription pathway—VDR—prostate cancer	0.000163	0.006	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—PRKACB—prostate cancer	0.000163	0.006	CbGpPWpGaD
Flumethasone Pivalate—Hypersensitivity—Docetaxel—prostate cancer	0.000162	0.0059	CcSEcCtD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—SIRT1—prostate cancer	0.00016	0.00591	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—TH—prostate cancer	0.000158	0.00583	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—prostate cancer	0.000158	0.00581	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Nuclear Receptors—ESR1—prostate cancer	0.000158	0.00581	CbGpPWpGaD
Flumethasone Pivalate—Hypersensitivity—Capecitabine—prostate cancer	0.000157	0.00571	CcSEcCtD
Flumethasone Pivalate—Amcinonide—NR3C1—prostate cancer	0.000156	0.0256	CrCbGaD
Flumethasone Pivalate—Pruritus—Docetaxel—prostate cancer	0.000156	0.00566	CcSEcCtD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA2—prostate cancer	0.000155	0.00571	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—HSP90B1—prostate cancer	0.000154	0.00569	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—NCOA2—prostate cancer	0.000154	0.00566	CbGpPWpGaD
Flumethasone Pivalate—Fluticasone furoate—NR3C1—prostate cancer	0.000153	0.0251	CrCbGaD
Flumethasone Pivalate—Pruritus—Capecitabine—prostate cancer	0.000151	0.00548	CcSEcCtD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—EGR1—prostate cancer	0.000149	0.00549	CbGpPWpGaD
Flumethasone Pivalate—Mometasone—NR3C1—prostate cancer	0.000149	0.0244	CrCbGaD
Flumethasone Pivalate—Rimexolone—NR3C1—prostate cancer	0.000147	0.0241	CrCbGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—GJA1—prostate cancer	0.000142	0.00523	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—prostate cancer	0.000141	0.0052	CbGpPWpGaD
Flumethasone Pivalate—Hypersensitivity—Prednisone—prostate cancer	0.00014	0.00509	CcSEcCtD
Flumethasone Pivalate—NR3C1—Adipogenesis—AHR—prostate cancer	0.000139	0.00512	CbGpPWpGaD
Flumethasone Pivalate—Rash—Docetaxel—prostate cancer	0.000139	0.00505	CcSEcCtD
Flumethasone Pivalate—Fluocinonide—NR3C1—prostate cancer	0.000139	0.0227	CrCbGaD
Flumethasone Pivalate—Beclomethasone—NR3C1—prostate cancer	0.000139	0.0227	CrCbGaD
Flumethasone Pivalate—Dermatitis—Docetaxel—prostate cancer	0.000139	0.00504	CcSEcCtD
Flumethasone Pivalate—NR3C1—Nuclear Receptor transcription pathway—PPARA—prostate cancer	0.000137	0.00506	CbGpPWpGaD
Flumethasone Pivalate—Alclometasone—NR3C1—prostate cancer	0.000135	0.0221	CrCbGaD
Flumethasone Pivalate—Fluocinolone Acetonide—NR3C1—prostate cancer	0.000135	0.0221	CrCbGaD
Flumethasone Pivalate—Rash—Capecitabine—prostate cancer	0.000134	0.00489	CcSEcCtD
Flumethasone Pivalate—Pruritus—Prednisone—prostate cancer	0.000134	0.00488	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Capecitabine—prostate cancer	0.000134	0.00488	CcSEcCtD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—ZNF160—prostate cancer	0.000134	0.00492	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—prostate cancer	0.000132	0.00487	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—EGR1—prostate cancer	0.000131	0.00484	CbGpPWpGaD
Flumethasone Pivalate—Clobetasol propionate—NR3C1—prostate cancer	0.000131	0.0215	CrCbGaD
Flumethasone Pivalate—Flunisolide—NR3C1—prostate cancer	0.000131	0.0215	CrCbGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA1—prostate cancer	0.000131	0.00481	CbGpPWpGaD
Flumethasone Pivalate—Paramethasone—NR3C1—prostate cancer	0.000129	0.0212	CrCbGaD
Flumethasone Pivalate—NR3C1—Circadian Clock—PPARA—prostate cancer	0.000129	0.00477	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—NCOA1—prostate cancer	0.000129	0.00477	CbGpPWpGaD
Flumethasone Pivalate—Fluorometholone—NR3C1—prostate cancer	0.000126	0.0207	CrCbGaD
Flumethasone Pivalate—NR3C1—Circadian Clock—HIF1A—prostate cancer	0.000126	0.00463	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—prostate cancer	0.000125	0.00462	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—prostate cancer	0.000125	0.00462	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Nuclear Receptor transcription pathway—ESR1—prostate cancer	0.000125	0.00459	CbGpPWpGaD
Flumethasone Pivalate—Fluticasone Propionate—CYP3A5—prostate cancer	0.000123	0.0202	CrCbGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—IL10—prostate cancer	0.000123	0.00453	CbGpPWpGaD
Flumethasone Pivalate—Methylprednisolone—NR3C1—prostate cancer	0.000122	0.02	CrCbGaD
Flumethasone Pivalate—Rash—Prednisone—prostate cancer	0.00012	0.00435	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Prednisone—prostate cancer	0.000119	0.00435	CcSEcCtD
Flumethasone Pivalate—Dexamethasone—CYP17A1—prostate cancer	0.000119	0.0195	CrCbGaD
Flumethasone Pivalate—Clobetasol propionate—CYP1A1—prostate cancer	0.000119	0.0195	CrCbGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—prostate cancer	0.000113	0.00415	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—GSK3B—prostate cancer	0.00011	0.00404	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—prostate cancer	0.000109	0.00403	CbGpPWpGaD
Flumethasone Pivalate—Hypersensitivity—Epirubicin—prostate cancer	0.000109	0.00398	CcSEcCtD
Flumethasone Pivalate—NR3C1—Adipogenesis—NCOA2—prostate cancer	0.000106	0.00391	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—CREBBP—prostate cancer	0.000106	0.0039	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—BAX—prostate cancer	0.000106	0.00389	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Epirubicin—prostate cancer	0.000105	0.00382	CcSEcCtD
Flumethasone Pivalate—Betamethasone—CYP19A1—prostate cancer	0.000104	0.0171	CrCbGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—HIF1A—prostate cancer	0.000104	0.00382	CbGpPWpGaD
Flumethasone Pivalate—Triamcinolone—NR3C1—prostate cancer	0.000103	0.0169	CrCbGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—GADD45A—prostate cancer	0.000103	0.00379	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Circadian Clock—CREBBP—prostate cancer	0.000103	0.00379	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—PLAU—prostate cancer	0.000103	0.00378	CbGpPWpGaD
Flumethasone Pivalate—Hypersensitivity—Doxorubicin—prostate cancer	0.000101	0.00368	CcSEcCtD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—PRKACB—prostate cancer	9.73e-05	0.00359	CbGpPWpGaD
Flumethasone Pivalate—Pruritus—Doxorubicin—prostate cancer	9.71e-05	0.00353	CcSEcCtD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—ESR1—prostate cancer	9.66e-05	0.00356	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Circadian Clock—SERPINE1—prostate cancer	9.63e-05	0.00355	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—prostate cancer	9.61e-05	0.00354	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Transcription factor regulation in adipogenesis—IL6—prostate cancer	9.54e-05	0.00351	CbGpPWpGaD
Flumethasone Pivalate—Rash—Epirubicin—prostate cancer	9.35e-05	0.0034	CcSEcCtD
Flumethasone Pivalate—NR3C1—Endoderm Differentiation—APC—prostate cancer	9.35e-05	0.00345	CbGpPWpGaD
Flumethasone Pivalate—Dermatitis—Epirubicin—prostate cancer	9.34e-05	0.0034	CcSEcCtD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—TBX5—prostate cancer	9.25e-05	0.00341	CbGpPWpGaD
Flumethasone Pivalate—Fluticasone Propionate—NR3C1—prostate cancer	9.21e-05	0.0151	CrCbGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—IL1RN—prostate cancer	9.05e-05	0.00334	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—MDM2—prostate cancer	8.99e-05	0.00331	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—NCOA1—prostate cancer	8.95e-05	0.0033	CbGpPWpGaD
Flumethasone Pivalate—Fluticasone furoate—CYP3A4—prostate cancer	8.88e-05	0.0146	CrCbGaD
Flumethasone Pivalate—Rash—Doxorubicin—prostate cancer	8.65e-05	0.00315	CcSEcCtD
Flumethasone Pivalate—Dermatitis—Doxorubicin—prostate cancer	8.65e-05	0.00315	CcSEcCtD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—prostate cancer	8.6e-05	0.00317	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—RXRA—prostate cancer	8.51e-05	0.00314	CbGpPWpGaD
Flumethasone Pivalate—Betamethasone—NR3C1—prostate cancer	8.44e-05	0.0138	CrCbGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—ESR2—prostate cancer	8.39e-05	0.00309	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—prostate cancer	8.38e-05	0.00309	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—TH—prostate cancer	8.33e-05	0.00307	CbGpPWpGaD
Flumethasone Pivalate—Dexamethasone—CYP1B1—prostate cancer	8.25e-05	0.0135	CrCbGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—EGR1—prostate cancer	7.85e-05	0.00289	CbGpPWpGaD
Flumethasone Pivalate—Alclometasone—CYP3A4—prostate cancer	7.81e-05	0.0128	CrCbGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—prostate cancer	7.72e-05	0.00285	CbGpPWpGaD
Flumethasone Pivalate—Flunisolide—CYP3A4—prostate cancer	7.6e-05	0.0125	CrCbGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—prostate cancer	7.54e-05	0.00278	CbGpPWpGaD
Flumethasone Pivalate—Paramethasone—CYP3A4—prostate cancer	7.51e-05	0.0123	CrCbGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—GJA1—prostate cancer	7.47e-05	0.00275	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—prostate cancer	7.46e-05	0.00275	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—AR—prostate cancer	7.41e-05	0.00273	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—LPL—prostate cancer	7.36e-05	0.00271	CbGpPWpGaD
Flumethasone Pivalate—Fluorometholone—CYP3A4—prostate cancer	7.33e-05	0.012	CrCbGaD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—EP300—prostate cancer	7.21e-05	0.00266	CbGpPWpGaD
Flumethasone Pivalate—Methylprednisolone—CYP3A4—prostate cancer	7.08e-05	0.0116	CrCbGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—prostate cancer	7.07e-05	0.0026	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of Androgen receptor activity—SRC—prostate cancer	7.01e-05	0.00258	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Circadian Clock—EP300—prostate cancer	7e-05	0.00258	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—CXCL8—prostate cancer	6.73e-05	0.00248	CbGpPWpGaD
Flumethasone Pivalate—Dexamethasone—CYP3A5—prostate cancer	6.57e-05	0.0108	CrCbGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—CDKN1B—prostate cancer	6.57e-05	0.00242	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—PPARA—prostate cancer	6.5e-05	0.0024	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—IL10—prostate cancer	6.48e-05	0.00239	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—IL2—prostate cancer	6.43e-05	0.00237	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—ZNF160—prostate cancer	6.43e-05	0.00237	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—BAZ2A—prostate cancer	6.43e-05	0.00237	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—SSR2—prostate cancer	6.43e-05	0.00237	CbGpPWpGaD
Flumethasone Pivalate—Dexamethasone—CYP2A6—prostate cancer	6.36e-05	0.0104	CrCbGaD
Flumethasone Pivalate—NR3C1—Endoderm Differentiation—CTNNB1—prostate cancer	6.35e-05	0.00234	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—MDM2—prostate cancer	6.34e-05	0.00234	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—HIF1A—prostate cancer	6.32e-05	0.00233	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—CCND1—prostate cancer	6.27e-05	0.00231	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—CTNNB1—prostate cancer	6.21e-05	0.00229	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—LEP—prostate cancer	6.17e-05	0.00227	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—MMP9—prostate cancer	6.08e-05	0.00224	CbGpPWpGaD
Flumethasone Pivalate—Dexamethasone—CYP19A1—prostate cancer	6.06e-05	0.00993	CrCbGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—PTEN—prostate cancer	6.05e-05	0.00223	CbGpPWpGaD
Flumethasone Pivalate—Triamcinolone—CYP3A4—prostate cancer	5.97e-05	0.00978	CrCbGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—prostate cancer	5.93e-05	0.00218	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—HNRNPH1—prostate cancer	5.88e-05	0.00217	CbGpPWpGaD
Flumethasone Pivalate—Triamcinolone—PTGS2—prostate cancer	5.85e-05	0.00958	CrCbGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—EP300—prostate cancer	5.77e-05	0.00213	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—IL2—prostate cancer	5.66e-05	0.00209	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—IRS1—prostate cancer	5.5e-05	0.00203	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—NFIC—prostate cancer	5.47e-05	0.00201	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—HIF1A—prostate cancer	5.46e-05	0.00201	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—prostate cancer	5.39e-05	0.00199	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—prostate cancer	5.34e-05	0.00197	CbGpPWpGaD
Flumethasone Pivalate—Fluticasone Propionate—CYP3A4—prostate cancer	5.34e-05	0.00875	CrCbGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—INS—prostate cancer	5.27e-05	0.00194	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—RPN2—prostate cancer	5.14e-05	0.00189	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—prostate cancer	5.13e-05	0.00189	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Endoderm Differentiation—TGFB1—prostate cancer	5.13e-05	0.00189	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—IGF1—prostate cancer	5.1e-05	0.00188	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—EP300—prostate cancer	5.08e-05	0.00187	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—prostate cancer	5.05e-05	0.00186	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—MYC—prostate cancer	5.03e-05	0.00185	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—TGFB1—prostate cancer	5.01e-05	0.00185	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—NPPA—prostate cancer	4.94e-05	0.00182	CbGpPWpGaD
Flumethasone Pivalate—Dexamethasone—NR3C1—prostate cancer	4.91e-05	0.00804	CrCbGaD
Flumethasone Pivalate—Betamethasone—CYP3A4—prostate cancer	4.89e-05	0.00801	CrCbGaD
Flumethasone Pivalate—NR3C1—Gene Expression—QARS—prostate cancer	4.87e-05	0.00179	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—MED12—prostate cancer	4.86e-05	0.00179	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—SERPINE1—prostate cancer	4.84e-05	0.00178	CbGpPWpGaD
Flumethasone Pivalate—Betamethasone—PTGS2—prostate cancer	4.79e-05	0.00785	CrCbGaD
Flumethasone Pivalate—Dexamethasone—CYP2E1—prostate cancer	4.52e-05	0.0074	CrCbGaD
Flumethasone Pivalate—Dexamethasone—CYP2C19—prostate cancer	4.47e-05	0.00733	CrCbGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—prostate cancer	4.47e-05	0.00165	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—CREBBP—prostate cancer	4.46e-05	0.00164	CbGpPWpGaD
Flumethasone Pivalate—Dexamethasone—CYP1A1—prostate cancer	4.46e-05	0.0073	CrCbGaD
Flumethasone Pivalate—NR3C1—Gene Expression—TBX5—prostate cancer	4.46e-05	0.00164	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—EIF3H—prostate cancer	4.14e-05	0.00153	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—TP53—prostate cancer	4.13e-05	0.00152	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—NCOA2—prostate cancer	3.88e-05	0.00143	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—CTNNB1—prostate cancer	3.78e-05	0.00139	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—AP-1 transcription factor network—IL6—prostate cancer	3.78e-05	0.00139	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—PARP1—prostate cancer	3.74e-05	0.00138	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—CDKN1A—prostate cancer	3.69e-05	0.00136	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—TP53—prostate cancer	3.64e-05	0.00134	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—ESR2—prostate cancer	3.55e-05	0.00131	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—CXCL8—prostate cancer	3.54e-05	0.00131	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—CASP3—prostate cancer	3.39e-05	0.00125	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—TET2—prostate cancer	3.38e-05	0.00124	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—MBD2—prostate cancer	3.38e-05	0.00124	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—IL6—prostate cancer	3.33e-05	0.00123	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—RPL12—prostate cancer	3.31e-05	0.00122	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—STAT3—prostate cancer	3.3e-05	0.00121	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	3.27e-05	0.0012	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—NCOA1—prostate cancer	3.27e-05	0.0012	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—AR—prostate cancer	3.13e-05	0.00115	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—RXRA—prostate cancer	3.11e-05	0.00115	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—prostate cancer	3.1e-05	0.00114	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—prostate cancer	3.07e-05	0.00113	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—TGFB1—prostate cancer	3.06e-05	0.00113	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—EIF3A—prostate cancer	3.04e-05	0.00112	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—EP300—prostate cancer	3.04e-05	0.00112	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	2.88e-05	0.00106	CbGpPWpGaD
Flumethasone Pivalate—Dexamethasone—CYP3A4—prostate cancer	2.85e-05	0.00466	CrCbGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—VDR—prostate cancer	2.81e-05	0.00104	CbGpPWpGaD
Flumethasone Pivalate—Dexamethasone—PTGS2—prostate cancer	2.79e-05	0.00456	CrCbGaD
Flumethasone Pivalate—NR3C1—Gene Expression—DNMT3B—prostate cancer	2.56e-05	0.000943	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—RPL10—prostate cancer	2.51e-05	0.000925	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—HIST1H2BG—prostate cancer	2.46e-05	0.000908	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—NPPA—prostate cancer	2.38e-05	0.000877	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—HIST1H4H—prostate cancer	2.38e-05	0.000877	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—PPARA—prostate cancer	2.37e-05	0.000875	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—MED12—prostate cancer	2.34e-05	0.000862	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Adipogenesis—IL6—prostate cancer	2.3e-05	0.000849	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—ESR1—prostate cancer	2.15e-05	0.000792	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—SIDS Susceptibility Pathways—IL6—prostate cancer	1.99e-05	0.000733	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—RPS19—prostate cancer	1.99e-05	0.000733	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—DNMT1—prostate cancer	1.9e-05	0.000701	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—CREBBP—prostate cancer	1.88e-05	0.000695	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—NCOA2—prostate cancer	1.87e-05	0.000688	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—EZH2—prostate cancer	1.84e-05	0.000679	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—PARP1—prostate cancer	1.8e-05	0.000664	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—SERPINE1—prostate cancer	1.77e-05	0.000651	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—HSPA1A—prostate cancer	1.71e-05	0.000629	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—ESR2—prostate cancer	1.71e-05	0.000629	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—NCOA1—prostate cancer	1.57e-05	0.00058	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—AR—prostate cancer	1.51e-05	0.000556	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—RXRA—prostate cancer	1.5e-05	0.000551	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—SIRT1—prostate cancer	1.37e-05	0.000507	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—VDR—prostate cancer	1.36e-05	0.000499	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—ERCC2—prostate cancer	1.24e-05	0.000457	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—PPARA—prostate cancer	1.14e-05	0.000421	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Generic Transcription Pathway—MYC—prostate cancer	1.12e-05	0.000412	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—ESR1—prostate cancer	1.04e-05	0.000382	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—CREBBP—prostate cancer	9.08e-06	0.000334	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—SERPINE1—prostate cancer	8.51e-06	0.000314	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—MYC—prostate cancer	5.39e-06	0.000198	CbGpPWpGaD
Flumethasone Pivalate—NR3C1—Gene Expression—AKT1—prostate cancer	3.74e-06	0.000138	CbGpPWpGaD
